協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/22 | 2,701 | 2,733 | 2,680 | 2,720 | +29 | +1.1% | 962,700 |
2020/05/21 | 2,673 | 2,707 | 2,650 | 2,691 | +27 | +1% | 902,900 |
2020/05/20 | 2,621 | 2,676 | 2,605 | 2,664 | +43 | +1.6% | 723,000 |
2020/05/19 | 2,647 | 2,654 | 2,618 | 2,621 | -3 | -0.1% | 846,100 |
2020/05/18 | 2,607 | 2,640 | 2,602 | 2,624 | +41 | +1.6% | 627,600 |
2020/05/15 | 2,607 | 2,610 | 2,547 | 2,583 | +12 | +0.5% | 786,800 |
2020/05/14 | 2,618 | 2,636 | 2,565 | 2,571 | -44 | -1.7% | 724,500 |
2020/05/13 | 2,636 | 2,655 | 2,611 | 2,615 | +15 | +0.6% | 998,800 |
2020/05/12 | 2,587 | 2,621 | 2,563 | 2,600 | +18 | +0.7% | 665,200 |
2020/05/11 | 2,616 | 2,653 | 2,580 | 2,582 | -32 | -1.2% | 937,700 |
2020/05/08 | 2,640 | 2,650 | 2,599 | 2,614 | +46 | +1.8% | 1,892,600 |
2020/05/07 | 2,517 | 2,584 | 2,462 | 2,568 | +99 | +4% | 1,551,000 |
2020/05/01 | 2,511 | 2,530 | 2,431 | 2,469 | -49 | -1.9% | 1,493,000 |
2020/04/30 | 2,514 | 2,535 | 2,476 | 2,518 | +64 | +2.6% | 1,435,100 |
2020/04/28 | 2,447 | 2,468 | 2,425 | 2,454 | +8 | +0.3% | 779,900 |
2020/04/27 | 2,458 | 2,461 | 2,422 | 2,446 | +5 | +0.2% | 841,100 |
2020/04/24 | 2,460 | 2,470 | 2,430 | 2,441 | +6 | +0.2% | 858,400 |
2020/04/23 | 2,420 | 2,446 | 2,409 | 2,435 | +17 | +0.7% | 742,200 |
2020/04/22 | 2,339 | 2,418 | 2,331 | 2,418 | +59 | +2.5% | 1,084,300 |
2020/04/21 | 2,380 | 2,397 | 2,350 | 2,359 | -20 | -0.8% | 708,200 |
2020/04/20 | 2,371 | 2,393 | 2,363 | 2,379 | -62 | -2.5% | 791,800 |
2020/04/17 | 2,433 | 2,452 | 2,403 | 2,441 | +51 | +2.1% | 823,400 |
2020/04/16 | 2,424 | 2,443 | 2,386 | 2,390 | -62 | -2.5% | 891,700 |
2020/04/15 | 2,490 | 2,493 | 2,425 | 2,452 | +12 | +0.5% | 1,066,200 |
2020/04/14 | 2,447 | 2,467 | 2,411 | 2,440 | +9 | +0.4% | 647,500 |
2020/04/13 | 2,431 | 2,460 | 2,420 | 2,431 | -32 | -1.3% | 552,600 |
2020/04/10 | 2,452 | 2,463 | 2,411 | 2,463 | +47 | +1.9% | 1,030,100 |
2020/04/09 | 2,396 | 2,416 | 2,363 | 2,416 | +13 | +0.5% | 768,200 |
2020/04/08 | 2,375 | 2,417 | 2,341 | 2,403 | +28 | +1.2% | 1,273,100 |
2020/04/07 | 2,435 | 2,456 | 2,309 | 2,375 | +28 | +1.2% | 1,012,400 |
2020/04/06 | 2,300 | 2,394 | 2,299 | 2,347 | +65 | +2.8% | 1,058,200 |
2020/04/03 | 2,287 | 2,377 | 2,256 | 2,282 | -37 | -1.6% | 1,103,700 |
2020/04/02 | 2,273 | 2,335 | 2,262 | 2,319 | +24 | +1% | 1,332,600 |
2020/04/01 | 2,421 | 2,444 | 2,267 | 2,295 | -127 | -5.2% | 1,171,000 |
2020/03/31 | 2,471 | 2,497 | 2,407 | 2,422 | -70 | -2.8% | 1,501,400 |
2020/03/30 | 2,415 | 2,498 | 2,389 | 2,492 | -8 | -0.3% | 2,182,600 |
2020/03/27 | 2,400 | 2,500 | 2,400 | 2,500 | +197 | +8.6% | 2,364,300 |
2020/03/26 | 2,318 | 2,376 | 2,269 | 2,303 | -37 | -1.6% | 1,430,400 |
2020/03/25 | 2,386 | 2,399 | 2,226 | 2,340 | +104 | +4.7% | 1,979,900 |
2020/03/24 | 2,139 | 2,239 | 2,113 | 2,236 | +147 | +7% | 2,775,700 |
2020/03/23 | 1,902 | 2,149 | 1,875 | 2,089 | +207 | +11% | 3,837,500 |
2020/03/19 | 2,035 | 2,047 | 1,849 | 1,882 | -110 | -5.5% | 3,817,900 |
2020/03/18 | 2,034 | 2,078 | 1,988 | 1,992 | -9 | -0.4% | 2,596,200 |
2020/03/17 | 2,019 | 2,091 | 1,964 | 2,001 | -64 | -3.1% | 3,182,500 |
2020/03/16 | 2,151 | 2,188 | 2,044 | 2,065 | -67 | -3.1% | 1,787,200 |
2020/03/13 | 2,094 | 2,208 | 2,023 | 2,132 | -138 | -6.1% | 2,687,200 |
2020/03/12 | 2,354 | 2,362 | 2,263 | 2,270 | -120 | -5% | 2,163,800 |
2020/03/11 | 2,393 | 2,409 | 2,362 | 2,390 | -28 | -1.2% | 1,604,400 |
2020/03/10 | 2,412 | 2,427 | 2,339 | 2,418 | -20 | -0.8% | 1,982,300 |
2020/03/09 | 2,514 | 2,514 | 2,410 | 2,438 | -126 | -4.9% | 1,609,500 |
1101~
1150
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム